APO Research
Talk to an analyst

APO RESEARCH · REPORT

Immunity Nutraceutical Ingredient

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Immunity Nutraceutical Ingredient Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

26 December 2025188 pages

Choose your research edition.

Industry ResearchImmunity Nutraceutical Ingredient Industry Research Report 2026122 pages · $2,950 USDIndustry Growth & TrendsGlobal Immunity Nutraceutical Ingredient Industry Growth and Trends Forecast to 203295 pages · $3,450 USDMarket StructureGlobal Immunity Nutraceutical Ingredient Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032188 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Immunity Nutraceutical Ingredient Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Immunity Nutraceutical Ingredient Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Immunity Nutraceutical Ingredient market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Immunity Nutraceutical Ingredient is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Immunity Nutraceutical Ingredient is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Immunity Nutraceutical Ingredient is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Immunity Nutraceutical Ingredient is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Immunity Nutraceutical Ingredient include Tate & Lyle PLC (U.K), Koninklijke DSM N.V. (Netherlands), Ingredion Incorporated (U.S), Arla Foods (Denmark) and Ajinomoto Co., Inc. (Japan), among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Immunity Nutraceutical Ingredient market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Immunity Nutraceutical Ingredient and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Immunity Nutraceutical Ingredient sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Immunity Nutraceutical Ingredient market size, projected growth trends, production technologies, key applications, and end-use industries.

Immunity Nutraceutical Ingredient Segment by Company

Tate & Lyle PLC (U.K)

Koninklijke DSM N.V. (Netherlands)

Ingredion Incorporated (U.S)

Arla Foods (Denmark)

Ajinomoto Co., Inc. (Japan)

Immunity Nutraceutical Ingredient Segment by Type

Carotenoids

Minerals

Omega-3 fatty acids

Fibers & specialty carbohydrates

Phytochemical and plant extracts

Others

Immunity Nutraceutical Ingredient Segment by Application

Dietary supplements

Functional beverages

Functional food

Personal care

Animal nutrition

Immunity Nutraceutical Ingredient Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Immunity Nutraceutical Ingredient market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Immunity Nutraceutical Ingredient and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Immunity Nutraceutical Ingredient.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Immunity Nutraceutical Ingredient market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Immunity Nutraceutical Ingredient manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Immunity Nutraceutical Ingredient in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Immunity Nutraceutical Ingredient in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Immunity Nutraceutical Ingredient Industry Trends Table 2. Immunity Nutraceutical Ingredient Industry Drivers Table 3. Immunity Nutraceutical Ingredient Industry Opportunities and Challenges Table 4. Immunity Nutraceutical Ingredient Industry Restraints Table 5. Global Immunity Nutraceutical Ingredient Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Immunity Nutraceutical Ingredient Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Immunity Nutraceutical Ingredient Sales by Manufacturers (Tons) & (2021-2026) Table 8. Global Immunity Nutraceutical Ingredient Sales Market Share by Manufacturers Table 9. Global Immunity Nutraceutical Ingredient Average Sales Price (US$/Kg) of Manufacturers (2021-2026) Table 10. Global Immunity Nutraceutical Ingredient Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Immunity Nutraceutical Ingredient Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Immunity Nutraceutical Ingredient Manufacturers, Product Type & Application Table 13. Global Immunity Nutraceutical Ingredient Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Immunity Nutraceutical Ingredient by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Carotenoids Table 17. Major Manufacturers of Minerals Table 18. Major Manufacturers of Omega-3 fatty acids Table 19. Major Manufacturers of Fibers & specialty carbohydrates Table 20. Major Manufacturers of Phytochemical and plant extracts Table 21. Major Manufacturers of Others Table 22. Global Immunity Nutraceutical Ingredient Sales by Type 2021 VS 2025 VS 2032 (Tons) Table 23. Global Immunity Nutraceutical Ingredient Sales by Type (2021-2026) & (Tons) Table 24. Global Immunity Nutraceutical Ingredient Sales by Type (2027-2032) & (Tons) Table 25. Global Immunity Nutraceutical Ingredient Sales Market Share by Type (2021-2026) Table 26. Global Immunity Nutraceutical Ingredient Sales Market Share by Type (2027-2032) Table 27. Global Immunity Nutraceutical Ingredient Revenue by Type 2021 VS 2025 VS 2032 (Tons) Table 28. Global Immunity Nutraceutical Ingredient Revenue by Type (2021-2026) & (Tons) Table 29. Global Immunity Nutraceutical Ingredient Revenue by Type (2027-2032) & (Tons) Table 30. Global Immunity Nutraceutical Ingredient Revenue Market Share by Type (2021-2026) Table 31. Global Immunity Nutraceutical Ingredient Revenue Market Share by Type (2027-2032) Table 32. Major Manufacturers of Dietary supplements Table 33. Major Manufacturers of Functional beverages Table 34. Major Manufacturers of Functional food Table 35. Major Manufacturers of Personal care Table 36. Major Manufacturers of Animal nutrition Table 37. Global Immunity Nutraceutical Ingredient Sales by Application 2021 VS 2025 VS 2032 (Tons) Table 38. Global Immunity Nutraceutical Ingredient Sales by Application (2021-2026) & (Tons) Table 39. Global Immunity Nutraceutical Ingredient Sales by Application (2027-2032) & (Tons) Table 40. Global Immunity Nutraceutical Ingredient Sales Market Share by Application (2021-2026) Table 41. Global Immunity Nutraceutical Ingredient Sales Market Share by Application (2027-2032) Table 42. Global Immunity Nutraceutical Ingredient Revenue by Application 2021 VS 2025 VS 2032 (Tons) Table 43. Global Immunity Nutraceutical Ingredient Revenue by Application (2021-2026) & (Tons) Table 44. Global Immunity Nutraceutical Ingredient Revenue by Application (2027-2032) & (Tons) Table 45. Global Immunity Nutraceutical Ingredient Revenue Market Share by Application (2021-2026) Table 46. Global Immunity Nutraceutical Ingredient Revenue Market Share by Application (2027-2032) Table 47. Global Immunity Nutraceutical Ingredient Sales by Region: 2021 VS 2025 VS 2032 (Tons) Table 48. Global Immunity Nutraceutical Ingredient Sales by Region (2021-2026) & (Tons) Table 49. Global Immunity Nutraceutical Ingredient Sales Market Share by Region (2021-2026) Table 50. Global Immunity Nutraceutical Ingredient Sales Forecasted by Region (2027-2032) & (Tons) Table 51. Global Immunity Nutraceutical Ingredient Sales Forecasted Market Share by Region (2027-2032) Table 52. North America Immunity Nutraceutical Ingredient Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (Tons) Table 53. North America Immunity Nutraceutical Ingredient Sales by Country (2021-2026) & (Tons) Table 54. North America Immunity Nutraceutical Ingredient Sales by Country (2027-2032) & (Tons) Table 55. Europe Immunity Nutraceutical Ingredient Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (Tons) Table 56. Europe Immunity Nutraceutical Ingredient Sales by Country (2021-2026) & (Tons) Table 57. Europe Immunity Nutraceutical Ingredient Sales by Country (2027-2032) & (Tons) Table 58. Asia Pacific Immunity Nutraceutical Ingredient Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (Tons) Table 59. Asia Pacific Immunity Nutraceutical Ingredient Sales by Country (2021-2026) & (Tons) Table 60. Asia Pacific Immunity Nutraceutical Ingredient Sales by Country (2027-2032) & (Tons) Table 61. South America, Middle East and Africa Immunity Nutraceutical Ingredient Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (Tons) Table 62. South America, Middle East and Africa Immunity Nutraceutical Ingredient Sales by Country (2021-2026) & (Tons) Table 63. South America, Middle East and Africa Immunity Nutraceutical Ingredient Sales by Country (2027-2032) & (Tons) Table 64. Global Immunity Nutraceutical Ingredient Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 65. Global Immunity Nutraceutical Ingredient Revenue by Region (2021-2026) & (US$ Million) Table 66. Global Immunity Nutraceutical Ingredient Revenue by Region (2027-2032) & (US$ Million) Table 67. Global Immunity Nutraceutical Ingredient Revenue Market Share by Region (2021-2026) Table 68. Global Immunity Nutraceutical Ingredient Revenue Market Share by Region (2027-2032) Table 69. Tate & Lyle PLC (U.K) Company Information Table 70. Tate & Lyle PLC (U.K) Business Overview Table 71. Tate & Lyle PLC (U.K) Immunity Nutraceutical Ingredient Sales (Tons), Price (US$/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. Tate & Lyle PLC (U.K) Immunity Nutraceutical Ingredient Product Portfolio Table 73. Tate & Lyle PLC (U.K) Recent Development Table 74. Koninklijke DSM N.V. (Netherlands) Company Information Table 75. Koninklijke DSM N.V. (Netherlands) Business Overview Table 76. Koninklijke DSM N.V. (Netherlands) Immunity Nutraceutical Ingredient Sales (Tons), Price (US$/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. Koninklijke DSM N.V. (Netherlands) Immunity Nutraceutical Ingredient Product Portfolio Table 78. Koninklijke DSM N.V. (Netherlands) Recent Development Table 79. Ingredion Incorporated (U.S) Company Information Table 80. Ingredion Incorporated (U.S) Business Overview Table 81. Ingredion Incorporated (U.S) Immunity Nutraceutical Ingredient Sales (Tons), Price (US$/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. Ingredion Incorporated (U.S) Immunity Nutraceutical Ingredient Product Portfolio Table 83. Ingredion Incorporated (U.S) Recent Development Table 84. Arla Foods (Denmark) Company Information Table 85. Arla Foods (Denmark) Business Overview Table 86. Arla Foods (Denmark) Immunity Nutraceutical Ingredient Sales (Tons), Price (US$/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. Arla Foods (Denmark) Immunity Nutraceutical Ingredient Product Portfolio Table 88. Arla Foods (Denmark) Recent Development Table 89. Ajinomoto Co., Inc. (Japan) Company Information Table 90. Ajinomoto Co., Inc. (Japan) Business Overview Table 91. Ajinomoto Co., Inc. (Japan) Immunity Nutraceutical Ingredient Sales (Tons), Price (US$/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 92. Ajinomoto Co., Inc. (Japan) Immunity Nutraceutical Ingredient Product Portfolio Table 93. Ajinomoto Co., Inc. (Japan) Recent Development Table 94. Key Raw Materials Table 95. Raw Materials Key Suppliers Table 96. Immunity Nutraceutical Ingredient Distributors List Table 97. Immunity Nutraceutical Ingredient Customers List Table 98. Research Programs/Design for This Report Table 99. Authors List of This Report Table 100. Secondary Sources Table 101. Primary Sources List of Figures Figure 1. Immunity Nutraceutical Ingredient Product Image Figure 2. Global Immunity Nutraceutical Ingredient Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Immunity Nutraceutical Ingredient Market Size (2021-2032) & (US$ Million) Figure 4. Global Immunity Nutraceutical Ingredient Sales (2021-2032) & (Tons) Figure 5. Global Immunity Nutraceutical Ingredient Average Price (US$/Kg) & (2021-2032) Figure 6. Global Top 5 and 10 Immunity Nutraceutical Ingredient Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Carotenoids Image Figure 9. Minerals Image Figure 10. Omega-3 fatty acids Image Figure 11. Fibers & specialty carbohydrates Image Figure 12. Phytochemical and plant extracts Image Figure 13. Others Image Figure 14. Global Immunity Nutraceutical Ingredient Sales by Type (2021 VS 2025 VS 2032) & (Tons) Figure 15. Global Immunity Nutraceutical Ingredient Sales Market Share 2021 VS 2025 VS 2032 Figure 16. Global Immunity Nutraceutical Ingredient Sales Market Share by Type (2021-2032) Figure 17. Global Immunity Nutraceutical Ingredient Revenue by Type (2021 VS 2025 VS 2032) & (Tons) Figure 18. Global Immunity Nutraceutical Ingredient Revenue Market Share 2021 VS 2025 VS 2032 Figure 19. Global Immunity Nutraceutical Ingredient Revenue Market Share by Type (2021-2032) Figure 20. Dietary supplements Image Figure 21. Functional beverages Image Figure 22. Functional food Image Figure 23. Personal care Image Figure 24. Animal nutrition Image Figure 25. Global Immunity Nutraceutical Ingredient Sales by Application (2021 VS 2025 VS 2032) & (Tons) Figure 26. Global Immunity Nutraceutical Ingredient Sales Market Share 2021 VS 2025 VS 2032 Figure 27. Global Immunity Nutraceutical Ingredient Sales Market Share by Application (2021-2032) Figure 28. Global Immunity Nutraceutical Ingredient Revenue by Application (2021 VS 2025 VS 2032) & (Tons) Figure 29. Global Immunity Nutraceutical Ingredient Revenue Market Share 2021 VS 2025 VS 2032 Figure 30. Global Immunity Nutraceutical Ingredient Revenue Market Share by Application (2021-2032) Figure 31. North America Immunity Nutraceutical Ingredient Sales and Growth Rate (2021-2032) & (Tons) Figure 32. North America Immunity Nutraceutical Ingredient Sales Market Share by Country (2021-2032) Figure 33. U.S. Immunity Nutraceutical Ingredient Sales and Growth Rate (2021-2032) & (Tons) Figure 34. Canada Immunity Nutraceutical Ingredient Sales and Growth Rate (2021-2032) & (Tons) Figure 35. Mexico Immunity Nutraceutical Ingredient Sales and Growth Rate (2021-2032) & (Tons) Figure 36. Europe Immunity Nutraceutical Ingredient Sales and Growth Rate (2021-2032) & (Tons) Figure 37. Europe Immunity Nutraceutical Ingredient Sales Market Share by Country (2021-2032) Figure 38. Germany Immunity Nutraceutical Ingredient Sales and Growth Rate (2021-2032) & (Tons) Figure 39. France Immunity Nutraceutical Ingredient Sales and Growth Rate (2021-2032) & (Tons) Figure 40. U.K. Immunity Nutraceutical Ingredient Sales and Growth Rate (2021-2032) & (Tons) Figure 41. Italy Immunity Nutraceutical Ingredient Sales and Growth Rate (2021-2032) & (Tons) Figure 42. Netherlands Immunity Nutraceutical Ingredient Sales and Growth Rate (2021-2032) & (Tons) Figure 43. Asia Pacific Immunity Nutraceutical Ingredient Sales and Growth Rate (2021-2032) & (Tons) Figure 44. Asia Pacific Immunity Nutraceutical Ingredient Sales Market Share by Country (2021-2032) Figure 45. China Immunity Nutraceutical Ingredient Sales and Growth Rate (2021-2032) & (Tons) Figure 46. Japan Immunity Nutraceutical Ingredient Sales and Growth Rate (2021-2032) & (Tons) Figure 47. South Korea Immunity Nutraceutical Ingredient Sales and Growth Rate (2021-2032) & (Tons) Figure 48. Southeast Asia Immunity Nutraceutical Ingredient Sales and Growth Rate (2021-2032) & (Tons) Figure 49. India Immunity Nutraceutical Ingredient Sales and Growth Rate (2021-2032) & (Tons) Figure 50. Australia Immunity Nutraceutical Ingredient Sales and Growth Rate (2021-2032) & (Tons) Figure 51. South America, Middle East and Africa Immunity Nutraceutical Ingredient Sales and Growth Rate (2021-2032) & (Tons) Figure 52. South America, Middle East and Africa Immunity Nutraceutical Ingredient Sales Market Share by Country (2021-2032) Figure 53. Brazil Immunity Nutraceutical Ingredient Sales and Growth Rate (2021-2032) & (Tons) Figure 54. South Africa Immunity Nutraceutical Ingredient Sales and Growth Rate (2021-2032) & (Tons) Figure 55. Saudi Arabia Immunity Nutraceutical Ingredient Sales and Growth Rate (2021-2032) & (Tons) Figure 56. Turkey Immunity Nutraceutical Ingredient Sales and Growth Rate (2021-2032) & (Tons) Figure 57. Argentina Immunity Nutraceutical Ingredient Sales and Growth Rate (2021-2032) & (Tons) Figure 58. UAE Immunity Nutraceutical Ingredient Sales and Growth Rate (2021-2032) & (Tons) Figure 59. Egypt Immunity Nutraceutical Ingredient Sales and Growth Rate (2021-2032) & (Tons) Figure 60. Chile Immunity Nutraceutical Ingredient Sales and Growth Rate (2021-2032) & (Tons) Figure 61. Global Immunity Nutraceutical Ingredient Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Global Immunity Nutraceutical Ingredient Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 63. North America Immunity Nutraceutical Ingredient Revenue (2021-2032) & (US$ Million) Figure 64. North America Immunity Nutraceutical Ingredient Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Europe Immunity Nutraceutical Ingredient Revenue (2021-2032) & (US$ Million) Figure 66. Europe Immunity Nutraceutical Ingredient Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 67. Asia-Pacific Immunity Nutraceutical Ingredient Revenue (2021-2032) & (US$ Million) Figure 68. Asia-Pacific Immunity Nutraceutical Ingredient Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 69. South America, Middle East and Africa Immunity Nutraceutical Ingredient Revenue (2021-2032) & (US$ Million) Figure 70. South America, Middle East and Africa Immunity Nutraceutical Ingredient Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 71. Immunity Nutraceutical Ingredient Value Chain Figure 72. Manufacturing Cost Structure Figure 73. Immunity Nutraceutical Ingredient Production Mode & Process Figure 74. Direct Comparison with Distribution Share Figure 75. Distributors Profiles Figure 76. Years Considered Figure 77. Research Process Figure 78. Key Executives Interviewed

Scope & coverage.

Types
  • Carotenoids
  • Minerals
  • Omega-3 fatty acids
  • Fibers & specialty carbohydrates
  • Phytochemical and plant extracts
  • Others
Applications
  • Dietary supplements
  • Functional beverages
  • Functional food
  • Personal care
  • Animal nutrition
Companies covered
  • Tate & Lyle PLC (U.K)
  • Koninklijke DSM N.V. (Netherlands)
  • Ingredion Incorporated (U.S)
  • Arla Foods (Denmark)
  • Ajinomoto Co., Inc. (Japan)

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Immunity Nutraceutical Ingredient Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Immunity Nutraceutical Ingredient Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Immunity Nutraceutical Ingredient Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Immunity Nutraceutical Ingredient Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Immunity Nutraceutical Ingredient Market Dynamics
  1. 2.1 Immunity Nutraceutical Ingredient Industry Trends
  2. 2.2 Immunity Nutraceutical Ingredient Industry Drivers
  3. 2.3 Immunity Nutraceutical Ingredient Industry Opportunities and Challenges
  4. 2.4 Immunity Nutraceutical Ingredient Industry Restraints
3 Immunity Nutraceutical Ingredient Market by Manufacturers
  1. 3.1 Global Immunity Nutraceutical Ingredient Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Immunity Nutraceutical Ingredient Sales by Manufacturers (2021-2026)
  3. 3.3 Global Immunity Nutraceutical Ingredient Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Immunity Nutraceutical Ingredient Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Immunity Nutraceutical Ingredient Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Immunity Nutraceutical Ingredient Manufacturers, Product Type & Application
  7. 3.7 Global Immunity Nutraceutical Ingredient Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Immunity Nutraceutical Ingredient Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Immunity Nutraceutical Ingredient Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Immunity Nutraceutical Ingredient Tier 1, Tier 2, and Tier 3
4 Immunity Nutraceutical Ingredient Market by Type
  1. 4.1 Immunity Nutraceutical Ingredient Type Introduction
  2. 4.1.1 Carotenoids
  3. 4.1.2 Minerals
  4. 4.1.3 Omega-3 fatty acids
  5. 4.1.4 Fibers & specialty carbohydrates
  6. 4.1.5 Phytochemical and plant extracts
  7. 4.1.6 Others
  8. 4.2 Global Immunity Nutraceutical Ingredient Sales by Type
  9. 4.2.1 Global Immunity Nutraceutical Ingredient Sales by Type (2021 VS 2025 VS 2032)
  10. 4.2.2 Global Immunity Nutraceutical Ingredient Sales by Type (2021-2032)
  11. 4.2.3 Global Immunity Nutraceutical Ingredient Sales Market Share by Type (2021-2032)
  12. 4.3 Global Immunity Nutraceutical Ingredient Revenue by Type
  13. 4.3.1 Global Immunity Nutraceutical Ingredient Revenue by Type (2021 VS 2025 VS 2032)
  14. 4.3.2 Global Immunity Nutraceutical Ingredient Revenue by Type (2021-2032)
  15. 4.3.3 Global Immunity Nutraceutical Ingredient Revenue Market Share by Type (2021-2032)
5 Immunity Nutraceutical Ingredient Market by Application
  1. 5.1 Immunity Nutraceutical Ingredient Application Introduction
  2. 5.1.1 Dietary supplements
  3. 5.1.2 Functional beverages
  4. 5.1.3 Functional food
  5. 5.1.4 Personal care
  6. 5.1.5 Animal nutrition
  7. 5.2 Global Immunity Nutraceutical Ingredient Sales by Application
  8. 5.2.1 Global Immunity Nutraceutical Ingredient Sales by Application (2021 VS 2025 VS 2032)
  9. 5.2.2 Global Immunity Nutraceutical Ingredient Sales by Application (2021-2032)
  10. 5.2.3 Global Immunity Nutraceutical Ingredient Sales Market Share by Application (2021-2032)
  11. 5.3 Global Immunity Nutraceutical Ingredient Revenue by Application
  12. 5.3.1 Global Immunity Nutraceutical Ingredient Revenue by Application (2021 VS 2025 VS 2032)
  13. 5.3.2 Global Immunity Nutraceutical Ingredient Revenue by Application (2021-2032)
  14. 5.3.3 Global Immunity Nutraceutical Ingredient Revenue Market Share by Application (2021-2032)
6 Global Immunity Nutraceutical Ingredient Sales by Region
  1. 6.1 Global Immunity Nutraceutical Ingredient Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Immunity Nutraceutical Ingredient Sales by Region (2021-2032)
  3. 6.2.1 Global Immunity Nutraceutical Ingredient Sales by Region (2021-2026)
  4. 6.2.2 Global Immunity Nutraceutical Ingredient Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Immunity Nutraceutical Ingredient Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Immunity Nutraceutical Ingredient Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Immunity Nutraceutical Ingredient Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Immunity Nutraceutical Ingredient Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Immunity Nutraceutical Ingredient Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Immunity Nutraceutical Ingredient Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Immunity Nutraceutical Ingredient Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Immunity Nutraceutical Ingredient Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Immunity Nutraceutical Ingredient Revenue by Region
  1. 7.1 Global Immunity Nutraceutical Ingredient Revenue by Region
  2. 7.1.1 Global Immunity Nutraceutical Ingredient Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Immunity Nutraceutical Ingredient Revenue by Region (2021-2026)
  4. 7.1.3 Global Immunity Nutraceutical Ingredient Revenue by Region (2027-2032)
  5. 7.1.4 Global Immunity Nutraceutical Ingredient Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Immunity Nutraceutical Ingredient Revenue (2021-2032)
  8. 7.2.2 North America Immunity Nutraceutical Ingredient Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Immunity Nutraceutical Ingredient Revenue (2021-2032)
  11. 7.3.2 Europe Immunity Nutraceutical Ingredient Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Immunity Nutraceutical Ingredient Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Immunity Nutraceutical Ingredient Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Immunity Nutraceutical Ingredient Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Immunity Nutraceutical Ingredient Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Tate & Lyle PLC (U.K)
  2. 8.1.1 Tate & Lyle PLC (U.K) Company Information
  3. 8.1.2 Tate & Lyle PLC (U.K) Business Overview
  4. 8.1.3 Tate & Lyle PLC (U.K) Immunity Nutraceutical Ingredient Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Tate & Lyle PLC (U.K) Immunity Nutraceutical Ingredient Product Portfolio
  6. 8.1.5 Tate & Lyle PLC (U.K) Recent Developments
  7. 8.2 Koninklijke DSM N.V. (Netherlands)
  8. 8.2.1 Koninklijke DSM N.V. (Netherlands) Company Information
  9. 8.2.2 Koninklijke DSM N.V. (Netherlands) Business Overview
  10. 8.2.3 Koninklijke DSM N.V. (Netherlands) Immunity Nutraceutical Ingredient Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Koninklijke DSM N.V. (Netherlands) Immunity Nutraceutical Ingredient Product Portfolio
  12. 8.2.5 Koninklijke DSM N.V. (Netherlands) Recent Developments
  13. 8.3 Ingredion Incorporated (U.S)
  14. 8.3.1 Ingredion Incorporated (U.S) Company Information
  15. 8.3.2 Ingredion Incorporated (U.S) Business Overview
  16. 8.3.3 Ingredion Incorporated (U.S) Immunity Nutraceutical Ingredient Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Ingredion Incorporated (U.S) Immunity Nutraceutical Ingredient Product Portfolio
  18. 8.3.5 Ingredion Incorporated (U.S) Recent Developments
  19. 8.4 Arla Foods (Denmark)
  20. 8.4.1 Arla Foods (Denmark) Company Information
  21. 8.4.2 Arla Foods (Denmark) Business Overview
  22. 8.4.3 Arla Foods (Denmark) Immunity Nutraceutical Ingredient Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Arla Foods (Denmark) Immunity Nutraceutical Ingredient Product Portfolio
  24. 8.4.5 Arla Foods (Denmark) Recent Developments
  25. 8.5 Ajinomoto Co., Inc. (Japan)
  26. 8.5.1 Ajinomoto Co., Inc. (Japan) Company Information
  27. 8.5.2 Ajinomoto Co., Inc. (Japan) Business Overview
  28. 8.5.3 Ajinomoto Co., Inc. (Japan) Immunity Nutraceutical Ingredient Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Ajinomoto Co., Inc. (Japan) Immunity Nutraceutical Ingredient Product Portfolio
  30. 8.5.5 Ajinomoto Co., Inc. (Japan) Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Immunity Nutraceutical Ingredient Value Chain Analysis
  2. 9.1.1 Immunity Nutraceutical Ingredient Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Immunity Nutraceutical Ingredient Production Mode & Process
  6. 9.2 Immunity Nutraceutical Ingredient Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Immunity Nutraceutical Ingredient Distributors
  9. 9.2.3 Immunity Nutraceutical Ingredient Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst